← All trials
NCT06613152
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2024
- Primary completion
- Oct 31, 2026
- Completion date
- Oct 31, 2028
- First posted
- Sep 25, 2024
- Last posted
- Sep 25, 2024
- Enrollment
- 9
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Qingdao Sino-Cell Biomedicine Co.,Ltd.Lead sponsor
- Qingdao Sino-Cell Biomedicine Co.,Ltd.Official
- Qingdao UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.